 | • レポートコード：MRC-IM30371 • 出版社/出版日：IMARC / 2022年11月 • レポート形態：英文、PDF、143ページ • 納品方法：Eメール • 産業分類：医療機器 |
| Single User | ￥359,856 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥647,856 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| グローバル調査会社のIMARC社は、2021年13.8億ドルであった世界の内視鏡的逆行性胆管膵管造影（ERCP）市場規模が2027年には21.1億ドルに達し、予測期間中、年平均7.20％成長すると予測しています。本調査レポートでは、内視鏡的逆行性胆管膵管造影（ERCP）の世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、製品別（内視鏡、エンドセラピー装置、可視化システム、エネルギー装置、その他）分析、手術別（胆道括約筋切開術、胆管ステント留置術、胆道拡張、膵括約筋切開術、その他）分析、エンドユーザー別（病院・診療所、外来手術センター、その他）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ファイブフォース分析、価格分析、競争状況などの項目を掲載しています。また、こちらの調査レポートに掲載されている企業情報には、Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, Fujifilm Holdings Corporation, Hobbs Medical Inc., Johnson & Johnson, Medi-Globe GmbH, Medtronic plc, Olympus Corporation, Shaili Endoscopy, Steris Corporationなどが含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界の内視鏡的逆行性胆管膵管造影（ERCP）市場規模：製品別 - 内視鏡の市場規模 - エンドセラピー装置の市場規模 - 可視化システムの市場規模 - エネルギー装置の市場規模 - その他内視鏡的逆行性胆管膵管造影（ERCP）の市場規模 ・世界の内視鏡的逆行性胆管膵管造影（ERCP）市場規模：手術別 - 胆道括約筋切開術における市場規模 - 胆管ステント留置術における市場規模 - 胆道拡張における市場規模 - 膵括約筋切開術における市場規模 - その他手術における市場規模 ・世界の内視鏡的逆行性胆管膵管造影（ERCP）市場規模：エンドユーザー別 - 病院・診療所における市場規模 - 外来手術センターにおける市場規模 - その他エンドユーザーにおける市場規模 ・世界の内視鏡的逆行性胆管膵管造影（ERCP）市場規模：地域別 - 北米の内視鏡的逆行性胆管膵管造影（ERCP）市場規模 - アジアの内視鏡的逆行性胆管膵管造影（ERCP）市場規模 - 欧州の内視鏡的逆行性胆管膵管造影（ERCP）市場規模 - 中南米の内視鏡的逆行性胆管膵管造影（ERCP）市場規模 - 中東・アフリカの内視鏡的逆行性胆管膵管造影（ERCP）市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ファイブフォース分析 ・価格分析 ・競争状況 |
The global endoscopic retrograde cholangiopancreatography market size reached US$ 1.38 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.11 Billion by 2027, exhibiting a growth rate (CAGR) of 7.20% during 2022-2027.
Endoscopic retrograde cholangiopancreatography (ERCP) is an imaging technique that diagnoses and treats abnormalities in the liver, gallbladder, bile ducts, and pancreas. It combines X-rays and a long, flexible, lightweight endoscope tube that passes through the esophagus, mouth, and stomach. It helps detect blockages, stones, infections, and tumors in the bile duct and fluid leakage from the pancreatic duct. Besides this, it is a less invasive procedure than open surgery and provides more detailed and accurate information about the pancreaticobiliary system. As a result, the demand for endotherapy devices is increasing across the globe to investigate dysphagia, diarrhea, weight loss, heartburn, and stool blood.
Endoscopic Retrograde Cholangiopancreatography Market Trends:
The growing global population and the rising prevalence of various chronic gastrointestinal (GI) and incessant biliary medical disorders, including Barrett’s disease, biliary, liver, Crohn’s, inflammatory bowel, and peptic ulcer disease, and gastroesophageal reflux disorder (GERD), represent one of the key factors positively influencing the market. In addition, the increasing occurrence of benign pancreas and liver tumors, especially among the geriatric population, along with the growing occurrence of cancer across the globe, is driving the market. In line with this, the expansion of hospitals and diagnostic centers is increasing the need for imaging techniques propelling the market growth. Furthermore, rising investments by governments and healthcare organizations of various countries in advanced endoscopy devices and improve endoscopy research is strengthening the market growth. Apart from this, the shifting consumer preference toward minimally invasive surgeries for a speedy recovery and minimal pain and rising awareness about ERCP devices like sphincterotomes are offering a favorable market outlook. Moreover, continuous improvements in healthcare infrastructure and a considerable rise in medical tourism are expected to propel market growth.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global endoscopic retrograde cholangiopancreatography market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, procedure and end user.
Breakup by Product:
Endoscope
Endotherapy Devices
Sphincterotomes
Lithotripter
Stents
Others
Visualization Systems
Energy Devices
Others
Breakup by Procedure:
Biliary Sphincterotomy
Biliary Stenting
Biliary Dialtation
Pancreatic Sphincterotomy
Pancreatic Duct Stenting
Pancreatic Duct Dilatation
Breakup by End User:
Hospitals and Clinics
Ambulatory Surgery Centers
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Boston Scientific Corporation, CONMED Corporation, Cook Group Incorporated, Fujifilm Holdings Corporation, Hobbs Medical Inc., Johnson & Johnson, Medi-Globe GmbH, Medtronic plc, Olympus Corporation, Shaili Endoscopy, Steris Corporation and Telemed Systems Inc.
Key Questions Answered in This Report:
How has the global endoscopic retrograde cholangiopancreatography market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global endoscopic retrograde cholangiopancreatography market?
What are the key regional markets?
What is the breakup of the market based on the product?
What is the breakup of the market based on the procedure?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global endoscopic retrograde cholangiopancreatography market and who are the key players?
What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Endoscopic Retrograde Cholangiopancreatography Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Endoscope
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Endotherapy Devices
6.2.1 Market Trends
6.2.2 Key Segments
6.2.2.1 Sphincterotomes
6.2.2.2 Lithotripter
6.2.2.3 Stents
6.2.2.4 Others
6.2.3 Market Forecast
6.3 Visualization Systems
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Energy Devices
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Others
6.5.1 Market Trends
6.5.2 Market Forecast
7 Market Breakup by Procedure
7.1 Biliary Sphincterotomy
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Biliary Stenting
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Biliary Dilatation
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Pancreatic Sphincterotomy
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Pancreatic Duct Stenting
7.5.1 Market Trends
7.5.2 Market Forecast
7.6 Pancreatic Duct Dilatation
7.6.1 Market Trends
7.6.2 Market Forecast
8 Market Breakup by End User
8.1 Hospitals and Clinics
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Ambulatory Surgery Centers
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Boston Scientific Corporation
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 CONMED Corporation
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Cook Group Incorporated
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.4 Fujifilm Holdings Corporation
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Hobbs Medical Inc.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Johnson & Johnson
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Medi-Globe GmbH
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.8 Medtronic plc
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Olympus Corporation
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Shaili Endoscopy
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.11 Steris Corporation
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.12 Telemed Systems Inc.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
Figure 2: Global: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Product (in %), 2021
Figure 5: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Procedure (in %), 2021
Figure 6: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by End User (in %), 2021
Figure 7: Global: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Region (in %), 2021
Figure 8: Global: Endoscopic Retrograde Cholangiopancreatography (Endoscope) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Endoscopic Retrograde Cholangiopancreatography (Endoscope) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Endoscopic Retrograde Cholangiopancreatography (Endotherapy Devices) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Endoscopic Retrograde Cholangiopancreatography (Endotherapy Devices) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Endoscopic Retrograde Cholangiopancreatography (Visualization Systems) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Endoscopic Retrograde Cholangiopancreatography (Visualization Systems) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Endoscopic Retrograde Cholangiopancreatography (Energy Devices) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Endoscopic Retrograde Cholangiopancreatography (Energy Devices) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Endoscopic Retrograde Cholangiopancreatography (Other Products) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Endoscopic Retrograde Cholangiopancreatography (Other Products) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Sphincterotomy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Sphincterotomy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Stenting) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Stenting) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Dilatation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Endoscopic Retrograde Cholangiopancreatography (Biliary Dilatation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Sphincterotomy) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Sphincterotomy) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Stenting) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Stenting) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Dilatation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Endoscopic Retrograde Cholangiopancreatography (Pancreatic Duct Dilatation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Endoscopic Retrograde Cholangiopancreatography (Hospitals and Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Endoscopic Retrograde Cholangiopancreatography (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Endoscopic Retrograde Cholangiopancreatography (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Endoscopic Retrograde Cholangiopancreatography (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Endoscopic Retrograde Cholangiopancreatography (Other End Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Endoscopic Retrograde Cholangiopancreatography (Other End Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: North America: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: North America: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: United States: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: United States: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Canada: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Canada: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Asia-Pacific: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Asia-Pacific: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: China: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: China: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Japan: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Japan: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: India: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: India: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: South Korea: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: South Korea: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Australia: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Australia: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Indonesia: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Indonesia: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: Others: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: Others: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: Europe: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Europe: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Germany: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Germany: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: France: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: France: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: United Kingdom: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: United Kingdom: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Italy: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Italy: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Spain: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Spain: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Russia: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Russia: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Others: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Others: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Latin America: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Latin America: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Brazil: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Brazil: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 78: Mexico: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 79: Mexico: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 80: Others: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 81: Others: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 82: Middle East and Africa: Endoscopic Retrograde Cholangiopancreatography Market: Sales Value (in Million US$), 2016 & 2021
Figure 83: Middle East and Africa: Endoscopic Retrograde Cholangiopancreatography Market: Breakup by Country (in %), 2021
Figure 84: Middle East and Africa: Endoscopic Retrograde Cholangiopancreatography Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 85: Global: Endoscopic Retrograde Cholangiopancreatography Industry: SWOT Analysis
Figure 86: Global: Endoscopic Retrograde Cholangiopancreatography Industry: Value Chain Analysis
Figure 87: Global: Endoscopic Retrograde Cholangiopancreatography Industry: Porter's Five Forces Analysis
• 日本語訳：内視鏡的逆行性胆管膵管造影（ERCP）の世界市場：動向・シェア・規模・予測
• レポートコード：MRC-IM30371 ▷ お問い合わせ（見積依頼・ご注文・質問）